Use of Highly Active Antiretroviral Therapy in a Cohort of HIV-Seropositive Women

Cook, Judith A.; Cohen, Mardge H.; Grey, Dennis; Kirstein, Lynn; Burke, Jane; Anastos, Kathryn; Palacio, Herminia; Richardson, Jean; Wilson, Tracey E.; Young, Mary
January 2002
American Journal of Public Health;Jan2002, Vol. 92 Issue 1, p82
Academic Journal
Objectives. This study examined longitudinal trends in use of highly active antiretroviral therapy (HAART) among a cohort of HIV-positive participants in the Women's Interagency HIV Study. Methods. Beginning in 1994, 1690 HIV-positive women reported detailed information about their use of antiretroviral therapy at 6-month study visits. Multivariate logistic and Cox regression analyses were used to estimate the likelihood of antiretroviral therapy and HAART use among women with study visits preceding and following HAART availability. Results. Before the availability of HAART, the cohort's likelihood of any antiretroviral therapy use was associated with clinical indicators (CD4 count, viral load, symptom presence) as well as behavioral factors (abstaining from drug and alcohol use, participating in clinical trials). After HAART became commercially available, newly emerging predictors included college education, private insurance, absence of injection drug use history, and not being African American. Conclusions. After the penetration of HAART into this cohort, additional differences emerged between HAART users and nonusers. These findings can inform public health efforts to enhance women's access to the most effective types of therapy. (Am J Public Health. 2002;92:82-87)


Related Articles

  • Adherence to Highly Active Antiretroviral Treatment in HIV-Infected Rwandan Women. Musiime, Stephenson; Muhairwe, Fred; Rutagengwa, Alfred; Mutimura, Eugene; Anastos, Kathryn; Hoover, Donald R.; Qiuhu, Shi; Munyazesa, Elizaphane; Emile, Ivan; Uwineza, Annette; Cowan, Ethan // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    Background: Scale-up of highly active antiretroviral treatment therapy (HAART) programs in Rwanda has been highly successful but data on adherence is limited. We examined HAART adherence in a large cohort of HIV+ Rwandan women. Methods: The Rwanda Women's Interassociation Study Assessment...

  • Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study. Dahab, Mison; Charalambous, Salome; Karstaedt, Alan S.; Fielding, Katherine L.; Hamilton, Robin; La Grange, Lettie; Churchyard, Gavin J.; Grant, Alison D. // BMC Public Health;2010, Vol. 10 Issue 1, p430 

    Background: Many national antiretroviral therapy (ART) programmes encourage providers to identify and address baseline factors associated with poor treatment outcomes, including modifiable adherence-related behaviours, before initiating ART. However, evidence on such predictors is scarce, and...

  • Assessing the effect of HAART on change in quality of life among HIV-infected women. Chenglong Liu; Weber, Kathleen; Robinson, Esther; Zheng Hui; Jacobson, Lisa P; Gange, Stephen J // AIDS Research & Therapy;2006, Vol. 3, p6 

    Background: The impact of highly active antiretroviral therapy (HAART) on health-related quality of life (QOL) of HIV-1 infected individuals in large prospective cohorts has not been well studied. Objective: To assess the effect of HAART on QOL by comparing HIV-infected women using HAART with...

  • Relationship between HIV/Highly Active Antiretroviral Therapy (HAART)—Associated Lipodystrophy Syndrome and Stavudine-Triphosphate Intracellular Levels in Patients with Stavudine-Based Antiretroviral Regimens. Domingo, Pere; Cabeza, Maria Carmen; Pruvost, Alain; Salazar, Juliana; del Mar Gutierrez, Maria; Mateo, Maria Gracia; Domingo, Joan C.; Fernandez, Irene; Villarroya, Francesc; Muñoz, Jessica; Vidal, Francesc; Baiget, Montserrat // Clinical Infectious Diseases;4/1/2010, Vol. 50 Issue 7, p1033 

    Background. The link between human immunodeficiency virus/highly active antiretroviral therapy (HAART)- associated lipodystrophy syndrome (HALS) and the use of thymidine analogues has been well established. However, to our knowledge, no relationship has been proven between intracellular levels...

  • Review of antiretroviral agents for the treatment of HIV infection. Stanic, Anela; Grana, Julie C. // Formulary;Feb2009, Vol. 44 Issue 2, p47 

    Research into the treatment of HIV infection has resulted in the development of 5 antiretroviral (ARV) drug classes: entry inhibitors, including fusion inhibitors and chemokine coreceptor (CCR) inhibitors; nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs); non-nucleoside reverse...

  • Human Immunodeficiency Virus Interactions with CD8+ T Lymphocytes. Saksena, Nitin K.; Jing Qin Wu; Potter, Simon J.; Wilkinson, John; Bin Wang // Current HIV Research;Jan2008, Vol. 6 Issue 1, p1 

    Human immunodeficiency virus (HIV)-specific CD8+ T cells can mediate anti-HIV activity by both cytolytic (cytotoxic T lymphocyte or CTL) and non-cytolytic mechanisms (antiviral) and play a crucial role in HIV pathogenesis. Both mechanisms actively contribute to the control of HIV in vivo. The...

  • Management of HIV-1 infection in adults. Nguyen, Thien Huong // Baylor University Medical Center Proceedings;Jan2009, Vol. 22 Issue 1, p62 

    The article presents information related to the management of human immunodeficiency virus (HIV) infection. According to the Joint United Nations Programme on HIV/AIDS 2008 report on the global AIDS epidemic, 30.8 million adults and 2 million children suffered HIV at the end of 2007. Due to the...

  • Highly Active Antiretroviral Therapy (HAART)-Plus: Next Steps to Enhance HAART in Resource-Limited Areas? Flanigan, Timothy P.; Wools-Kaloustain, Kara; Harwell, Joseph; Cu-Uvin, Susan; Kimaiyo, Sylvester; Carter, E. Jane // Clinical Infectious Diseases;12/1/2007, Vol. 45 Issue 11, p1499 

    The author reflects on the result of the study conducted by H. Ramadhani and colleagues which reveals the predictors of incomplete adherence and virologic failure among 150 patients who have been receiving fixed-dose combination (FDC) therapy and highly active antiretroviral therapy (HAART) for...

  • Optimal timing for initiation of antiretroviral therapy: a prospective study on treatment naive HIV patients. Chakravarty, Jaya; Singh, Avinash; Singh, Anup; Rai, Madhukar; Gupta, Anoop; Agarwal, Amit; Sundar, Shyam // BMC Infectious Diseases;2012 Supplement, Vol. 12 Issue Supplment 1, p1 

    The article presents a prospective study on the optimal timing for initiation of antiretroviral therapy in naive HIV patients. The authors observed the immunological disease progression of patients for 1 year, which resulted to higher number of opportunistic infection in patients. They indicate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics